1.a introducción a la fda


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Summary of presentation
  • En término de número de líneas de todos los productos bajo la jurisdicción de la FDA,
  • Partner with foreign counterparts to create global coalitions of regulators focused on ensuring and improving global product safety Build global data information systems and networks and proactively share data with peers Expand intelligence gathering, with an increased focus on risk analytics and thoroughly modernized IT capabilities Effectively allocate agency resources based on risk, leveraging the combined efforts of government, industry and public and private third parties
  • 1.a introducción a la fda

    1. 1. The U.S. Food and Drug Administration: FDA in Latin America:Overview, Goals, Objectives, Opportunities Michael Rogers, M.S. Director, Latin America Office Food and Drug Administration 1
    2. 2. FDA in Latin America• Overview: – FDA’s organization and Mission • Office of International Programs – History and overview of FDA offices overseas • structure of the FDA Latin American Office (LAO). – Challenges of Globalization • The triggering factors → International • Roles and Responsibilities of LAO – Ongoing Activities – Future Opportunities • Identifying sources and ways to obtain information about FDA regulated products within the Region • Working with industry and foreign governments. 2
    3. 3. FDA MissionFDA Mission• FDA is charged with protecting the public health by ensuring the safety, effectiveness, and security of human and veterinary drugs, biological products, and medical devices; ensuring the safety of foods, cosmetics, and radiation-emitting products; and regulating tobacco products.• Specifically, FDA is responsible for advancing the public health by: – Helping to speed innovations that make foods safer and make medicines and devices safer and more effective; – Ensuring the public has accurate, science-based information they need to use medicines, devices, and foods to improve their health; – Regulating the manufacture, marketing, and distribution of tobacco products and reducing tobacco use by minors; and, – Addressing the Nation’s counterterrorism capability and ensuring the security of the supply of foods and medical products.Vision• FDA is dedicated to world-class excellence as a science-based regulatory agency with a public health mission. We aim to provide effective and innovative leadership — both domestically and internationally — to protect health, prevent illness, prolong life, and promote wellness. 3
    4. 4. 4 4
    5. 5. Mission and Vision of OIPVision• The FDAs Office of International Programs (OIP) advances the mission of the FDA and public health worldwide in partnership with other FDA components, other U.S. agencies, foreign governments and international organizations.Mission• OIPs mission is to lead, manage, and coordinate all of FDAs international activities, with the following goals.• Effect an affirmative public health agenda in the international area;• Enhance and maximize FDAs communications and interactions globally, to assure they reflect the Agencys policies and best scientific, legal, and policy thinking;• Assure that FDA international communications and interaction are consistent with the U.S. Department of Health and Human Services public health objectives, and,• Leverage resources with counterpart agencies to meet our public health missions. 5
    6. 6. 6
    7. 7. FDA Resources Compared Imports 25,000 20,000Lines∗ in Thousands 15,000 10,000 5,000 0 1995 1997 1999 2001 2003 2005 2007 2009 2011 est Fiscal Year FTEs LINES ∗Lines are shipments of a certain type of product (i.e. if a container includes 1 million bottles of water and 5 million bottles of club soda, that would be one entry containing two lines). 7
    8. 8. Foreign Inspections2500200015001000500 0 2008 2009 2010 2011 Fiscal Year 8
    9. 9. Principales países latinoamericanosexportadores de productos regulados por FDA 2011* PAIS ENTRADAS Mexico 7,970,177 República Dominicana 137,520 Chile 121,529 Guatemala 113,100 Costa Rica 108,364 Colombia 89,774 Brasil 88,380 El Salvador 81,114 Perú 74,662 9 *Fuente: ORADSS (Datos no Oficiales)
    10. 10. Principales causas de rechazos de productos colombianos 2011 Medicamentos no aprobados Colores no inocuos Etiquetado: no en inglés, ingredientes no listados y errores en general LACF: sin FCE ni SID Plaguicidas Falta etiquetado nutricional 10
    11. 11. Algunas alertas de Importación que afectan productos alimenticios colombianos http://www.accessdata.fda.gov/CMS_IA/countr y_CO.html Quesos: contaminación  Violaciones a NLEA microbiológica  Aflatoxinas en alimentos general Aletas de tiburón: suciedad  Frutas y vegetales frescos: Pez espada: metil mercurio contaminación con patógenos Tamarindo: suciedad  Plaguicidas en alimentos frescos Hojas de Stevia y procesados: lulo, mora, fresa, uchuva, albahaca Colores: ilegales o no declarados  Salmonella: te de manzanilla, Pescado a vacío: C. botulinum albahaca 11
    12. 12. Changing Nature of Risk in Global Supply Chains 12
    13. 13. Latest wakeup calls• Melamine in pets foods and in infant formula• Listeria in cheese, guacamole, etc.• DEG in toothpaste, in glycerin used in teething gel and in cough syrup• Salmonella in mamey pulp, peppers, cantaloupes, etc.• Counterfeit diabetic test strips• Gentamicin pyrogenic reactions• Heparin (Condroitin Sulfate adulterant?) 13
    14. 14. http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/Glo 14
    15. 15. History of FDA’s Latin American Office• OIP’s Foreign Offices – 7 foreign offices – Asia Pacific, China, India, Europe, Middle East and North Africa, and Sub-Saharan Africa, Latin America Office (LAO) • administrative offices in Maryland• LAO – January 6, 2009 • First office officially dedicated at the US Embassy in San José, Costa Rica • Ceremony attended by Leavitt, Von Eschenbach, Valdez and Seligman. • Trip includes a visit to the Gorgas Research Institute in Panamá City, Panamá. 15
    16. 16. FDA Foreign Offices 16
    17. 17. 17
    18. 18. Regulatory Challenges for FDA• more imported products• more international providers of these products• more international sub-contractors being used for manufacturing and clinical trials• more complex supply chains• imports coming from countries, whose regulatory systems are not fully developed• more opportunity for economic fraud, counterfeiting, acts of bioterrorism 18
    19. 19. Today’s Reality• Import Statistics• Borders can no longer be a first line of defense• It is very difficult to detect harmful products at the border• Products grown, processed, manufactured, tested, transported to standards of safety & high quality – best defense – primary prevention – build in safety & quality at the source 19
    20. 20. Ongoing Activities• Country profiles• Validating contacts within the Region• Build capacity and an understanding of foreign regulatory systems• Environmental Scans• Project to enhance the class 1 recall process• Analytical Papers• Presentations and Translating documents• Training on FSMA• Collaboration with industry 20
    21. 21. Future Activities• Pathway to Global Product Safety and Quality• Inspections• Product mapping• Recalls• Identifying sources of information within the Region that have a direct impact on FDA regulated products or firms shipping to the U.S.• Leverage information generated by foreign governments 21
    22. 22. Contact Information and Questions • US-FDA-LAO@fda.hhs.gov • US Embassy Costa Rica (506) 2519-2224 • Michael Rogers, (506) 2519-2223 22